<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03779490</url>
  </required_header>
  <id_info>
    <org_study_id>2017-21</org_study_id>
    <nct_id>NCT03779490</nct_id>
  </id_info>
  <brief_title>Transcatheter Repair of Tricuspid Regurgitation With Edwards Cardioband TR System Post Market Study (TriBAND)</brief_title>
  <acronym>TriBAND</acronym>
  <official_title>Transcatheter Repair of Tricuspid Regurgitation With Cardioband TR System Post-Market Clinical Follow-Up Study (TriBAND): A European Prospective, Multicenter Post-market Clinical Follow-up Study to Assess Transcatheter Tricuspid Valve Repair With Edwards Cardioband TR System in Patients With Symptomatic Chronic Functional Tricuspid Regurgitation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to assess the safety and the effectiveness of the Cardioband
      Tricuspid Reconstruction System.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is to assess the safety and the effectiveness of the Cardioband
      Tricuspid Reconstruction System. This is a multi-center, prospective, single-arm Post-Market
      Clinical Follow up Study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 24, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2026</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Procedure Success</measure>
    <time_frame>Hospital discharge, 2-7 days post-procedure</time_frame>
    <description>Reduction in severity of Tricuspid Regurgitation at discharge.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Event Rate</measure>
    <time_frame>30 days, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years</time_frame>
    <description>Rates of major adverse</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure Success</measure>
    <time_frame>30 days, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years</time_frame>
    <description>Reduction in severity of Tricuspid Regurgitation (TR) severity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life - KCCQ</measure>
    <time_frame>30 days, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years</time_frame>
    <description>Improvement in Quality of Life as assessed by KCCQ.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life - EQ-5D-5L</measure>
    <time_frame>30 days, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years</time_frame>
    <description>Improvement in Quality of Life as assessed by EQ-5D-5L</description>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Tricuspid Regurgitation</condition>
  <condition>Tricuspid Insufficiency</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcatheter Tricuspid Valve Repair</intervention_name>
    <description>Transcatheter Tricuspid Valve Repair with Edwards Cardioband TR</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Symptomatic patients with chronic functional tricuspid regurgitation (FTR)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        -  Inclusion Criteria:

               -  Eighteen (18) years of age or older

               -  Moderate or greater functional Tricuspid Regurgitation (TR)

               -  Patient is eligible to receive the Edwards Cardioband TR System per the current
                  approved indications for use.

          -  Exclusion Criteria:

               -  Patients deemed anatomically unsuitable for the device by echocardiography

               -  Patients in whom transesophageal echocardiography (TEE) is contraindicated

               -  Previous tricuspid valve repair or replacement

               -  Severe aortic, mitral and / or pulmonic valve stenosis

               -  Severe aortic, mitral and / or pulmonic valve regurgitation

               -  Renal Insufficiency requiring dialysis or severe kidney renal disease

               -  Life expectancy of less than twelve months

               -  Patient is pregnant or lactating
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Georg Nickenig, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Bonn, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephan Windecker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inselspital Bern, Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>TMTT Clinical Affairs</last_name>
    <phone>+1 (949) 250-2500</phone>
    <email>TMTT_Clinical@edwards.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universitätsklinik der Ruhr-Universität Bochum</name>
      <address>
        <city>Bad Oeynhausen</city>
        <state>North Rhine Westphalia</state>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kai Friedrichs, MD</last_name>
      <phone>+49 5731 973 667</phone>
      <email>kpfriedrichs@hdz-nrw.de</email>
    </contact>
    <investigator>
      <last_name>Kai Friedrichs, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herzzentrum der UniKlinik Köln</name>
      <address>
        <city>Cologne</city>
        <state>NRW</state>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Baldus, MD</last_name>
      <email>stephan.baldus@uk-koeln.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. - Johannes-Hospital</name>
      <address>
        <city>Dortmund</city>
        <state>NRW</state>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helge Möllmann, MD</last_name>
      <phone>+49231 1843</phone>
      <phone_ext>35111</phone_ext>
      <email>helge.moellmann@joho-dortmund.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Berlin Charité-Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Lauten</last_name>
      <phone>+49 30 450 513 736</phone>
      <email>alexander.lauten@charite.de</email>
    </contact>
    <investigator>
      <last_name>Alexander Lauten</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>51312</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georg Nickenig</last_name>
      <phone>+49 228 287 15259</phone>
      <email>georg.nickenig@ukb.uni-bonn.de</email>
    </contact>
    <investigator>
      <last_name>Georg Nickenig</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Universitätsklinik Dresden</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Axel Linke</last_name>
      <phone>+49 351 450 1710</phone>
      <email>axel.linke@herzzentrum-dresden.com</email>
    </contact>
    <investigator>
      <last_name>Axel Linke</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Erlangen</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Arnold</last_name>
      <phone>0049 9131 853 5301</phone>
      <email>martin.arnold@uk-erlangen.de</email>
    </contact>
    <investigator>
      <last_name>Martin Arnold</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Göttingen, Herzzentrum Göttingen</name>
      <address>
        <city>Göttingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudius Jacobshagen, MD</last_name>
      <email>jacobshagen@med.uni-goettingen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik St. Gerorg</name>
      <address>
        <city>Hamburg</city>
        <zip>20099</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felix Meincke, MD</last_name>
      <email>f.meincke@asklepios.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Katholisches Marienkrankenhaus</name>
      <address>
        <city>Hamburg</city>
        <zip>22087</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrich Schäfer, MD</last_name>
      <phone>+49 40 2546</phone>
      <phone_ext>2102</phone_ext>
      <email>schaefer.kardiologie@marienkrankenhaus.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin der Johannes Gutenberg Universität Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Von Bardeleben</last_name>
      <phone>+49 6131 172892</phone>
      <email>stephan.von_Bardeleben@unimedizin-mainz.de</email>
    </contact>
    <investigator>
      <last_name>Stephan Von Bardeleben</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsspital Bern (Inselspital)</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stephan Windecker, MD</last_name>
      <phone>+41 31 632 44 97</phone>
      <email>stephan.windecker@insel.ch</email>
    </contact>
    <investigator>
      <last_name>Stephan Windecker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Switzerland</country>
  </location_countries>
  <removed_countries>
    <country>Sweden</country>
  </removed_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>December 15, 2018</study_first_submitted>
  <study_first_submitted_qc>December 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2018</study_first_posted>
  <last_update_submitted>June 11, 2020</last_update_submitted>
  <last_update_submitted_qc>June 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Edwards Cardioband TR</keyword>
  <keyword>Annuloplasty</keyword>
  <keyword>Tricuspid Repair</keyword>
  <keyword>Tricuspid Valve</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tricuspid Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

